Procaps
- Company typePrivate
- Founded1977
- HeadquartersBarranquilla, Colombia
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Procaps does
Procaps, S.A. is a privately held Colombian pharmaceutical company founded in 1977 and headquartered in Barranquilla. The company develops, manufactures, and markets pharmaceutical and health products across four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (highly complex medicines for hospital-sector use), Vital Care (OTC and generic health products for the family), and Diabetrics (wellness and management products for people with diabetes). It operates across 11 Latin American countries through an integrated manufacturing and marketing platform, and serves multiple customer segments including prescription patients, hospital systems, OTC consumers, and chronic-disease patients.
The company's commercial model combines direct sales to healthcare providers and hospitals for prescription and clinical products, retail and wholesale distribution for OTC and generic products, and proprietary e-commerce brand portals (Gumivit for gummy vitamins, Dolofen for pain relief, Diabetrics for diabetes management) for direct consumer engagement. The company employs 1,001–5,000 people and is led by founder and president Ruben Minski. Procaps explicitly disclaims any relationship with ProCaps Laboratories, Inc. in the United States and has no U.S. operations or product offerings under the Procaps name. No public ticker, ownership structure, or investor disclosures are available in the source data.
Core capabilities center on pharmaceutical formulation, manufacturing, and multi-channel distribution across Latin America, supported by regulatory certifications and an ESG/corporate governance framework. No AI/ML, digital health platform, or proprietary technology stack capabilities are disclosed in the available sources. The technology base is described as traditional pharmaceutical development and manufacturing, including specialized formats such as gummy vitamins, rather than technology-native operations.
Procaps firmographics
Firmographics- Name
- Procaps
- Legal name
- Procaps, S.A.
- Website
- https://procapslaboratorios.com
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Where Procaps is headquartered
LocationHeadquarters
- HQ city
- Barranquilla
- HQ country
- Colombia
- HQ region
- Latin America
Offices1 record
Markets served
Procaps business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Prescription Pharmaceuticals (Farma): Development, manufacturing and marketing of exclusive prescription brand medicines in Latin America
- Clinical Specialities: Highly complex medicines for critical hospital sector processing
- Vital Care (OTC/Generic): Over-the-counter and generic health products for the entire family
- Diabetrics: Diabetes management products and wellness solutions for people with diabetes
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Procaps product offering
Product offeringCore offering
Procaps develops, manufactures, and markets pharmaceutical products across four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions). It also operates branded consumer portals for gummy vitamins (Gumivit) and pain relief products (Dolofen), distributing across 11 Latin American countries.
Product overview
Procaps is a pharmaceutical company that develops, manufactures, and markets health products across four therapeutic lines: Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions). The company operates brand portals including Gumivit (gummy vitamins) and Dolofen (pain relief products), serving patients and communities across 11 countries in Latin America.
Differentiator
Problem solved
Functional benefit
Brands
- Farma: Exclusive prescription brand medicines developed, manufactured and marketed in Latin America
- Clinical Specialities
- Vital Care
- Diabetrics
- Gumivit
- Dolofen
Products and services
- Farma Exclusive prescription brand medicines developed, manufactured, and marketed by Procaps for patients requiring treatment of chronic and acute conditions across Latin America. Targeted at pharmacies, distributors, and prescribing physicians.
- Clinical Specialities Highly complex medicines developed, manufactured, and marketed by Procaps for critical processings in the hospital sector. Targeted at hospital procurement and pharmacy buyers across Latin America.
- Vital Care Over-the-counter (OTC) and generic health products developed, manufactured, and marketed by Procaps for the entire family. Distributed through retail channels for self-medication and general health maintenance.
- Diabetrics Well-being and quality of life products for people with diabetes (PWD) and their environment, positioning Procaps as their ally for effective management of chronic conditions. Distributed via the diabetrics.com brand portal and through regional channels.
- Gumivit Branded gummy vitamin nutritional supplements manufactured by Procaps and sold through the Gumivit brand portal (gumivit.com.co). Targeted at consumers seeking palatable nutritional supplementation.
- Dolofen Branded pain relief health products manufactured by Procaps and sold through the Dolofen brand portal (dolofen.com.co). Targeted at consumers seeking accessible pain relief solutions.
Companies that use Procaps
Customer profileSegments5 records
Ideal customer profiles3 records
Procaps technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Procaps partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Procaps competitors and assessment
Company assessmentDirect peers
- Tecnoquímicas: Colombian pharmaceutical manufacturer with prescription, OTC, and consumer health brands across LatAm; directly comparable as a domestic Colombian pharma peer operating across overlapping therapeutic lines.
- Genomma Lab Internacional: Mexican pharmaceutical company focused on OTC and personal care brands across Latin America; highly comparable given the similar OTC + branded pharma mix and multi-country LatAm presence.
- Eurofarma Laboratórios: Brazilian multinational pharmaceutical manufacturer with prescription, hospital, OTC, and generics across Latin America; comparable scale and diversified therapeutic line strategy.
- EMS Pharma: Brazil's largest pharmaceutical company by units sold, with broad prescription, generic, and OTC portfolios; comparable as a high-volume regional pharma manufacturer in LatAm.
- Aché Laboratórios: Brazilian pharmaceutical company with prescription, OTC, and consumer health products; comparable therapeutic breadth and multi-channel LatAm distribution.
- Grupo Insud: Argentine pharmaceutical conglomerate spanning prescription, hospital, OTC, and consumer health brands across LatAm; comparable integrated pharma platform model.
- Laboratorios Roemmers: Argentine pharmaceutical company with prescription, OTC, and consumer health brands; comparable therapeutic diversification and LatAm footprint.
- Laboratorios Bagó: Argentine multinational pharmaceutical company operating across prescription, hospital, and OTC segments in LatAm; comparable regional pharma manufacturer profile.
- Megalabs: Latin American pharmaceutical company headquartered in Uruguay with branded generics, OTC, and hospital products across 18+ countries; comparable multi-country LatAm pharma footprint.
Broad incumbents
- Bayer: Global pharmaceutical and consumer health incumbent with established LatAm presence across prescription, OTC, and consumer health; broad incumbent competing in overlapping therapeutic categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Procaps social profiles
Digital presenceProcaps financial estimates
Financial estimateRevenue estimate
Valuation estimate
Procaps leadership team
Management profileNumber of profiles
Profiles1 record
Procaps funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Procaps M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Procaps
What does Procaps do?
Procaps develops, manufactures, and markets pharmaceutical products across four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions). It also operates branded consumer portals for gummy vitamins (Gumivit) and pain relief products (Dolofen), distributing across 11 Latin American countries.
Is Procaps a public or private company?
Procaps is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Procaps founded?
Procaps was founded in 1977. It employs 1,001 to 5,000 people.
Where is Procaps based?
Procaps is headquartered in Barranquilla, Colombia, in the Latin America region.
How does Procaps make money?
Four revenue lines are on record. Prescription Pharmaceuticals (Farma) is the primary driver. The others are clinical Specialities, vital Care (OTC/Generic) and diabetrics.
Who are Procaps's main competitors?
Direct peers on record are Tecnoquímicas, Genomma Lab Internacional, Eurofarma Laboratórios, EMS Pharma, Aché Laboratórios, Grupo Insud, Laboratorios Roemmers, Laboratorios Bagó and Megalabs. Bayer is listed as a broad incumbent.
Does Procaps have an API?
No public API is recorded for Procaps.